Drug Type Gene therapy |
Synonyms EMD 301, EMD301 |
Target- |
Mechanism Gene modulators |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hypercholesterolemia | Preclinical | US | Emendo Biotherapeutics, Inc.Startup | 15 Sep 2023 |
Skin Diseases | Preclinical | US | Emendo Biotherapeutics, Inc.Startup | - |